{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:39:11Z","timestamp":1793705951477,"version":"4.6.1"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"Importance<\/jats:title>Recurrent coronary events in patients with recent myocardial infarction remain a major clinical problem. Noninvasive measures of coronary atherosclerotic disease activity have the potential to identify individuals at greatest risk.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess whether coronary atherosclerotic plaque activity as assessed by noninvasive imaging is associated with recurrent coronary events in patients with myocardial infarction.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This prospective, longitudinal, international multicenter cohort study recruited participants aged 50 years or older with multivessel coronary artery disease and recent (within 21 days) myocardial infarction between September 2015 and February 2020, with a minimum 2 years\u2019 follow-up.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Coronary 18<\/jats:sup>F-sodium fluoride positron emission tomography and coronary computed tomography angiography.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Total coronary atherosclerotic plaque activity was assessed by 18<\/jats:sup>F-sodium fluoride uptake. The primary end point was cardiac death or nonfatal myocardial infarction but was expanded during study conduct to include unscheduled coronary revascularization due to lower than anticipated primary event rates.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 2684 patients screened, 995 were eligible, 712 attended for imaging, and 704 completed an interpretable scan and comprised the study population. The mean (SD) age of participants was 63.8 (8.2) years, and most were male (601 [85%]). Total coronary atherosclerotic plaque activity was identified in 421 participants (60%). After a median follow-up of 4 years (IQR, 3-5 years), 141 participants (20%) experienced the primary end point: 9 had cardiac death, 49 had nonfatal myocardial infarction, and 83 had unscheduled coronary revascularizations. Increased coronary plaque activity was not associated with the primary end point (hazard ratio [HR], 1.25; 95% CI, 0.89-1.76; P<\/jats:italic>\u2009=\u2009.20) or unscheduled revascularization (HR, 0.98; 95% CI, 0.64-1.49; P<\/jats:italic>\u2009=\u2009.91) but was associated with the secondary end point of cardiac death or nonfatal myocardial infarction (47 of 421 patients with high plaque activity [11.2%] vs 19 of 283 with low plaque activity [6.7%]; HR, 1.82; 95% CI, 1.07-3.10; P<\/jats:italic>\u2009=\u2009.03) and all-cause mortality (30 of 421 patients with high plaque activity [7.1%] vs 9 of 283 with low plaque activity [3.2%]; HR, 2.43; 95% CI, 1.15-5.12; P<\/jats:italic>\u2009=\u2009.02). After adjustment for differences in baseline clinical characteristics, coronary angiography findings, and Global Registry of Acute Coronary Events score, high coronary plaque activity was associated with cardiac death or nonfatal myocardial infarction (HR, 1.76; 95% CI, 1.00-3.10; P<\/jats:italic>\u2009=\u2009.05) but not with all-cause mortality (HR, 2.01; 95% CI, 0.90-4.49; P<\/jats:italic>\u2009=\u2009.09).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study of patients with recent myocardial infarction, coronary atherosclerotic plaque activity was not associated with the primary composite end point. The findings suggest that risk of cardiovascular death or myocardial infarction in patients with elevated plaque activity warrants further research to explore its incremental prognostic implications.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2023.1729","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T11:33:49Z","timestamp":1687952029000},"page":"755","source":"Crossref","is-referenced-by-count":59,"title":["Coronary Atherosclerotic Plaque Activity and Future Coronary Events"],"prefix":"10.1001","volume":"8","author":[{"given":"Alastair","family":"Moss","sequence":"first","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"},{"name":"National Institute for Health and Care Research, Leicester Biomedical Research Centre, University of Leicester, Leicester, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Daghem","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Tzolos","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed N.","family":"Meah","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anda","family":"Bularga","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Adamson","sequence":"additional","affiliation":[{"name":"Christchurch Heart Institute, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kwiecinski","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Dawson","sequence":"additional","affiliation":[{"name":"Aberdeen Cardiovascular and Diabetes Centre, University of Aberdeen, Aberdeen, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthiban","family":"Arumugam","sequence":"additional","affiliation":[{"name":"Manchester University, NHS Foundation Trust, Manchester, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikant","family":"Sabharwal","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals, NHS Foundation Trust, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Greenwood","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon N.","family":"Townend","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Calvert","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, University of Cambridge, Cambridge, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H. F.","family":"Rudd","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Cambridge, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Berman","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Verjans","sequence":"additional","affiliation":[{"name":"Adelaide Medical School, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Slomka","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damini","family":"Dey","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Forsyth","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Murdoch","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steff","family":"Lewis","sequence":"additional","affiliation":[{"name":"Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Mills","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"},{"name":"Usher Institute, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J. R.","family":"van Beek","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Williams","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Dweck","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[{"name":"Edinburgh Imaging, The University of Edinburgh, Edinburgh, Scotland"},{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PREFFIR Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny","family":"Briola","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Armstrong","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Macdonald","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Scott","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Milne","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey","family":"Milne","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Battison","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R","family":"Wilkins","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F","family":"Storey","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Razavi","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Wallberg","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Mycock","sequence":"additional","affiliation":[{"name":"for the PREFFIR Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"hoi230029r1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cct.2012.01.001","article-title":"TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients.","volume":"33","author":"D\u2019Ascenzo","year":"2012","journal-title":"Contemp Clin Trials"},{"issue":"19","key":"hoi230029r2","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events.","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"issue":"1","key":"hoi230029r3","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-001984","article-title":"External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome.","volume":"9","author":"van der Sangen","year":"2022","journal-title":"Open Heart"},{"issue":"14","key":"hoi230029r4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"issue":"15","key":"hoi230029r5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction.","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"hoi230029r6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis.","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"issue":"10209","key":"hoi230029r7","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0140-6736(19)31794-5","article-title":"Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.","volume":"394","author":"Waksman","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"hoi230029r8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.jacc.2019.07.062","article-title":"From detecting the vulnerable plaque to managing the vulnerable patient.","volume":"74","author":"Arbab-Zadeh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"hoi230029r9","doi-asserted-by":"publisher","first-page":"l1945","DOI":"10.1136\/bmj.l1945","article-title":"Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data.","volume":"365","author":"Haase","year":"2019","journal-title":"BMJ"},{"issue":"17","key":"hoi230029r10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMoa2200963","article-title":"CT or invasive coronary angiography in stable chest pain.","volume":"386","author":"Maurovich-Horvat","year":"2022","journal-title":"N Engl J Med"},{"issue":"9918","key":"hoi230029r11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography identifies ruptured and high-risk coronary atherosclerotic plaques.","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"hoi230029r12","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F]FDG PET imaging.","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"hoi230029r13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jacc.2011.12.037","article-title":"Coronary arterial 18F-NaF uptake: a novel marker of cardiovascular risk.","volume":"59","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"hoi230029r14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2020.12.010","article-title":"Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome.","volume":"319","author":"Majeed","year":"2021","journal-title":"Atherosclerosis"},{"key":"hoi230029r15","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1038\/ncomms8495","article-title":"Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.","volume":"6","author":"Irkle","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"hoi230029r16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.118.007835","article-title":"18F-fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in PET-CT images.","volume":"12","author":"Creager","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"hoi230029r17","doi-asserted-by":"publisher","first-page":"20172","DOI":"10.1038\/s41598-020-77391-6","article-title":"Ex vivo 18F-fluoride uptake and hydroxyapatite deposition in human coronary atherosclerosis.","volume":"10","author":"Moss","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"hoi230029r18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1161\/ATVBAHA.119.312737","article-title":"18F-sodium fluoride positron emission tomography\/computed tomography in ex vivo human coronary arteries with histological correlation.","volume":"40","author":"Youn","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"hoi230029r19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jcmg.2022.03.018","article-title":"In vivo coronary 18F-sodium fluoride activity. correlations with coronary plaque histological vulnerability and physiological environment.","volume":"16","author":"Wen","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"hoi230029r20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1161\/ATVBAHA.120.315364","article-title":"18F-sodium fluoride positron emission tomography activity predicts the development of new coronary artery calcifications.","volume":"41","author":"Bellinge","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"hoi230029r21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.120.011438","article-title":"Coronary 18F-fluoride uptake and progression of coronary artery calcification.","volume":"13","author":"Doris","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"issue":"24","key":"hoi230029r22","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1016\/j.jacc.2020.04.046","article-title":"18F-sodium fluoride coronary uptake predicts outcome in patients with coronary artery disease.","volume":"75","author":"Kwiecinski","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi230029r23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jcmg.2021.12.013","article-title":"Thoracic aortic 18F-sodium fluoride activity and ischemic stroke in patients with established cardiovascular disease.","volume":"15","author":"Fletcher","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"20","key":"hoi230029r24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"hoi230029r25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.118.008325","article-title":"Feasibility of coronary 18F-sodium fluoride PET assessment with the utilization of previously acquired CT angiography.","volume":"11","author":"Kwiecinski","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"hoi230029r26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jcct.2011.06.001","article-title":"SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT.","volume":"5","author":"Halliburton","year":"2011","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"11","key":"hoi230029r27","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2967\/jnumed.110.082263","article-title":"SNM practice guideline for sodium 18F-fluoride PET\/CT bone scans 1.0.","volume":"51","author":"Segall","year":"2010","journal-title":"J Nucl Med"},{"issue":"6","key":"hoi230029r28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jcct.2022.07.002","article-title":"CAD-RADS\u2122 2.0\u20142022 Coronary Artery Disease-Reporting and Data System: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI).","volume":"16","author":"Cury","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"2","key":"hoi230029r29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12350-018-1317-5","article-title":"Optimization of reconstruction and quantification of motion-corrected coronary PET-CT.","volume":"27","author":"Doris","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"hoi230029r30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2967\/jnumed.115.162990","article-title":"Motion correction of 18F-sodium fluoride PET for imaging coronary atherosclerotic plaques.","volume":"57","author":"Rubeaux","year":"2016","journal-title":"J Nucl Med"},{"issue":"7","key":"hoi230029r31","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1007\/s00259-019-04667-z","article-title":"Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden.","volume":"47","author":"Kwiecinski","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"hoi230029r32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/ehjci\/jez152","article-title":"Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography.","volume":"21","author":"Kwiecinski","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"hoi230029r33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12350-020-02221-1","article-title":"Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity.","volume":"29","author":"Tzolos","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"hoi230029r34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12350-020-02245-7","article-title":"Respiration-averaged CT versus standard CT attenuation map for correction of 18F-sodium fluoride uptake in coronary atherosclerotic lesions on hybrid PET\/CT.","volume":"29","author":"Tzolos","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"10240","key":"hoi230029r35","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(20)30635-8","article-title":"Clinical endpoint adjudication.","volume":"395","author":"Meah","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"hoi230029r36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000043.pub2","article-title":"Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.","volume":"3","author":"Ndounga Diakou","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"hoi230029r37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jacc.2009.02.068","article-title":"Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome.","volume":"54","author":"Motoyama","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi230029r38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.006704","article-title":"Clinical relevance of 18F-sodium fluoride positron-emission tomography in non-invasive identification of high-risk plaque in patients with coronary artery disease.","volume":"10","author":"Lee","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"hoi230029r39","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/ehjci\/jeab276","article-title":"Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography\/magnetic resonance imaging for in vivo plaque characterization.","volume":"23","author":"Wurster","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"hoi230029r40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/heartjnl-2020-317165","article-title":"Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China.","volume":"107","author":"Song","year":"2020","journal-title":"Heart"},{"issue":"22","key":"hoi230029r41","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/eurheartj\/ehq326","article-title":"Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).","volume":"31","author":"Fox","year":"2010","journal-title":"Eur Heart J"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2806690\/jamacardiology_moss_2023_oi_230029_1690482627.92283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T11:02:45Z","timestamp":1691578965000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2806690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.1729","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}